Related Experiment Videos

Interleukins, interferons and tumor necrosis factor in cancer treatment

AAOHN Journal : Official Journal of the American Association of Occupational Health Nurses

|April 1, 1987

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

The consequences of treatment and disease in patients with primary CNS non-Hodgkin's lymphoma: cognitive function and performance status. North Central Cancer Treatment Group.

Neuro-oncology·2001

A randomized Phase II study of interleukin-2 with and without beta-interferon for patients with advanced non-small cell lung cancer: an Eastern Cooperative Oncology Group study (PZ586).

Lung cancer (Amsterdam, Netherlands)·1999

Primary central nervous system non-Hodgkin's lymphoma (PCNSL): survival advantages with combined initial therapy? A final report of the North Central Cancer Treatment Group (NCCTG) Study 86-72-52.

International journal of radiation oncology, biology, physics·1999

Primary central nervous system non-Hodgkin's lymphoma: survival advantages with combined initial therapy?

International journal of radiation oncology, biology, physics·1995

Metabolic characterization of human non-Hodgkin's lymphomas in vivo with the use of proton-decoupled phosphorus magnetic resonance spectroscopy.

Cancer research·1995

Phase I study of sequentially administered recombinant tumor necrosis factor and recombinant interleukin-2.

Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy·1995

See all related articles